LGALS1 and neoplasm: Interestingly, our studies have revealed a further induction of the stromal galectin-1 in response to radiation exposure in 2D, 3D and various preclinical tumor models [24, 25] and (Figure 4), indicating the possibility of combining radiation with targeted nanochemotherapy and reduced side effects.